Chargement en cours...

DRES-01. EFFICACY OF EGFR PLUS TNF INHIBITION IN A PRECLINICAL MODEL OF GLIOBLASTOMA

EGFR gene amplification and mutation are common in glioblastoma (GBM), but EGFR inhibition is not effective in treating this tumor. EGFR inhibition may fail because EGFR is not a driver of the malignant phenotype in GBM, or because adaptive compensatory mechanisms are triggered by EGFR inhibition th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Guo, Gao, Gong, Ke, Sarkaria, Jann, Habib, Amyn
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847388/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.289
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!